|
|
|
|
|
非在研适应症- |
最高研发阶段临床前 |
首次获批国家/地区- |
首次获批日期- |
|
作用机制microRNA let-7i-5p抑制剂 |
|
|
|
非在研适应症- |
最高研发阶段药物发现 |
首次获批国家/地区- |
首次获批日期- |
Comparison of benefits and safety between a CAPD technique with one icodextrin containing and two glucose containing dialysate a day and a CAPD technique with four exchanges of glucose-containing dialysates: a multicentre, prospective, randomized controlled trial
100 项与 The Catholic University of Korea 相关的临床结果
0 项与 The Catholic University of Korea 相关的专利(医药)
100 项与 The Catholic University of Korea 相关的药物交易
100 项与 The Catholic University of Korea 相关的转化医学